000 00900 a2200277 4500
005 20250512023224.0
264 0 _c19860917
008 198609s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(86)92090-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNewling, D W
245 0 0 _aDeferred treatment in prostatic cancer.
_h[electronic resource]
260 _bLancet (London, England)
_cAug 1986
300 _a278-9 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasms, Hormone-Dependent
_xtherapy
650 0 4 _aProstatic Neoplasms
_xtherapy
650 0 4 _aTime Factors
700 1 _aHall, R R
700 1 _aPowell, P H
773 0 _tLancet (London, England)
_gvol. 2
_gno. 8501
_gp. 278-9
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(86)92090-8
_zAvailable from publisher's website
999 _c2880139
_d2880139